Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal for ImmunoTherapy of CancerOpen Access

High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMyrto MoutafiKBKatherine BatesTAThazin Nwe Aung

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Moutafi et al. (2024) studied this question.

synapsesocial.com/papers/68e669b0b6db6435875f5cd4https://doi.org/10.1136/jitc-2024-009039
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 1045: A novel epithelial tumor signature predicts survival and response to PD-1 blockade in non-small cell lung cancer2026
  2. 283P Comprehensive molecular profiling of tumor tissue and liquid biopsy in NSCLC patients treated with immune-checkpoint inhibitors2026
  3. 3Abstract 6391: Spatial proteomic profiling unveils pre-existing anti-tumor immunity as a hallmark of exceptional benefit from immunotherapy in NSCLC2024
  4. 4Abstract 7748: Immune-related RNA-seq biomarker-based clustering reveals heterogeneous immunotherapy responses and guides subtype-specific strategies in metastatic NSCLC2026
  5. 5Tumor-derived serum proteotypes to predict response to immune therapy in patients with limited disease small-cell lung cancer.2024